Contraceptive Devices Market Outlook (2022-2033)

Historic Data: 2022-2024   |   Base Year: 2025   |   Forecast Period: 2026-2033
Report Content: Market Scope, Market Segmentation, Market Dynamics, and Competitive Analysis

Report Coverage:
  • Product Type (Hormonal Contraceptives, Barrier Contraceptives)
  • Type (Male Contraceptive Devices, Female Contraceptive Devices)
  • Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, and Others)

No. of Pages: 400
Report Code: BMIPUB00032581
Category: Life Sciences
Contraceptive Devices Market
Buy Now

The Contraceptive Devices market size is expected to reach US$ 45.65 billion by 2033 from US$ 28.22 billion in 2025. The market is estimated to record a CAGR of 6.05% from 2026 to 2033.

Executive Summary and Global Market Analysis:

Contraceptive devices are specialized medical apparatuses and barrier tools designed to prevent pregnancy by interfering with the process of ovulation, fertilization, or implantation. Contraceptive options include Long-Acting Reversible Contraceptives (LARCs) like IUDs and implants, barrier methods such as condoms, diaphragms, and cervical caps, and permanent surgical implants for sterilization. There is an increased awareness of family planning, emphasis on women's empowerment and education, and government-supported policies that emphasize access to modern forms of contraception. Innovative LARCs, such as sleek, low-dose IUDs and biodegradable implants that dissolve on their own, are making contraception simpler and more accessible than ever.

However, several challenges can restrain market growth: high initial procurement costs for long-acting devices and specialized insertion procedures can limit adoption in resource-poor settings or areas with inadequate healthcare infrastructure. Stringent regulatory hurdles, including intensive safety monitoring and clinical trial requirements for hormonal systems, lengthen the time-to-market for innovative products. Moreover, the industry faces constraints due to social and cultural stigmas in certain regions, as well as concerns regarding hormonal side effects, such as mood changes or cycle irregularities, which remain a leading cause of device discontinuation among users.

Despite these hurdles, the market holds immense opportunities in the universal mandate for expanded reproductive rights and the accelerating deployment of non-hormonal, molecular-targeted technologies that minimize systemic side effects. The expansion of digital contraception (FDA-cleared apps) that utilize predictive algorithms for fertility tracking and the development of multipurpose prevention technologies (MPTs), which combine contraception with anti-retroviral protection, are expected to create significant opportunities for market growth.

Contraceptive Devices Market - Strategic Insights:

global-market-strategic-framework
Get more information on this report

Contraceptive Devices Market Segmentation Analysis:

Key segments that contributed to the derivation of the Contraceptive Devices market analysis are product type, type, and distribution channel.

  • By Product Type, the market is bifurcated into Hormonal Contraceptives and Barrier Contraceptives.
  • By Type, the market is bifurcated into Male Contraceptive Devices and Female Contraceptive Devices.
  • By Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, and Others.

Contraceptive Devices Market Drivers and Opportunities:

Population Management and Growing Focus on Women’s Health

Governments and international health organizations are increasing reproductive health programs to help manage population growth and promote economic empowerment, especially in developing countries. Supportive regulations, better education, and more awareness about sexual health have helped reduce the stigma around contraception. The increasing prevalence of sexually transmitted diseases (STDs) has led to a greater adoption of barrier contraceptives, such as condoms, for the prevention of both pregnancy and disease. Furthermore, demographic trends, including a younger population and professionals postponing parenthood, continue to drive demand for reliable, long-term contraceptive methods. As healthcare infrastructure grows worldwide, easier access to these devices through pharmacies and public clinics supports steady market growth. 

Long-Acting Reversibles and Digital Access

A high-value opportunity in the contraceptive market is the rapid uptake of Long-Acting reversible Contraceptives (LARCs), including intrauterine devices (IUDs), and sub-dermal devices. These devices are increasingly preferred for their greater efficacy compared to daily-adherence methods. Smaller, flexible, hormone-free copper systems are gaining popularity, particularly among adolescents. Digital tools, including e-pharmacies and subscription services, are improving access to contraception by increasing convenience and privacy. Additionally, there is significant potential for the development of new male contraceptives. As shared reproductive responsibility gains importance, non-surgical, reversible male devices like vas-occlusive gels represent a large, untapped market. Manufacturers that use eco-friendly materials, including biodegradable or non-latex options, are well-positioned to attract environmentally conscious consumers.

Contraceptive Devices Market Size and Share Analysis:

The Contraceptive Devices market demonstrates steady growth, with size and share analysis revealing evolving trends and competitive positioning among key players. The report further examines subsegments categorized within product type, type, and distribution channel, offering insights into their contribution to overall market performance.

For instance, the Hormonal Contraceptives segment accounts for a significant portion of the market, fueled by the widespread adoption of Long-Acting Reversible Contraceptives (LARCs) such as intrauterine devices (IUDs) and subdermal implants. In 2025, a prominent trend is the shift toward "ultra-low-dose" and progestin-only formulations, which are favored by users seeking to minimize cardiovascular risks and estrogen-related side effects. Meanwhile, Barrier Contraceptives (product type) maintain a strong presence due to their critical role in preventing sexually transmitted infections (STIs), with innovations in non-latex materials and enhanced sensation designs broadening their appeal among consumers with sensitivities.

Contraceptive Devices Market Report Highlights:

Report Attribute Details
Market size in 2025 US$ 28.22 Billion
Market Size by 2033 US$ 45.65 Billion
Global CAGR (2026 - 2033)6.05%
Historical Data 2022-2024
Forecast period 2026-2033
Segments Covered By Product Type
  • Hormonal Contraceptives
  • Barrier Contraceptives
By Type
  • Male Contraceptive Devices
  • Female Contraceptive Devices
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Clinics
  • Online Channel
  • Others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • Belgium
  • Austria
  • Finland
  • Denmark
  • Greece
  • Poland
  • Romania
  • Russia
  • Ukraine
  • Czech Republic
  • Slovakia
  • Bulgaria
  • Italy
  • Luxembourg
  • Germany
  • Switzerland
  • France
  • Netherlands
  • Norway
  • Portugal
  • Spain
  • Sweden
  • United Kingdom
Asia-Pacific
  • Australia
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Bangladesh
  • New Zealand
  • Taiwan
South and Central America
  • Brazil
  • Argentina
  • Peru
  • Chile
  • Colombia
Middle East and Africa
  • Bahrain
  • Kuwait
  • Oman
  • Qatar
  • Saudi Arabia
  • United Arab Emirates
  • Turkiye
  • South Africa
  • Egypt
  • Algeria
  • Nigeria
Market leaders and key company profiles
  • Bayer AG
  • Pfizer Inc.
  • Janssen Global Services, LLC
  • Teva Pharmaceutical Industries Ltd.
  • Merck Sharp & Dohme Corp.
  • Mylan N.V.
  • Reckitt Benckiser Group plc.
  • Veru Inc.
  • Medisafe Distribution Inc.
Get more information on this report

Contraceptive Devices Market Report Coverage and Deliverables:

The Contraceptive Devices Market Size and Forecast (2022–2033) report provides a detailed analysis of the market covering below areas:

  • Contraceptive Devices market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Contraceptive Devices market trends, as well as market dynamics such as drivers, restraints, and key opportunities
  • Contraceptive Devices market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
  • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Contraceptive Devices market
  • Detailed company profiles, including SWOT analysis

Contraceptive Devices Market Geographic Insights:

The geographical scope of the Contraceptive Devices market report is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

The Asia-Pacific Contraceptive Devices Market is segmented into China, Japan, South Korea, India, Australia, New Zealand, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Taiwan, Bangladesh, and the Rest of Asia. This region is witnessing significant growth in the market due to its massive population base and increasing focus on family planning. China and India lead the regional demand, fueled by government-led population control programs and rising healthcare investments. Japan and South Korea contribute through advanced healthcare infrastructure and high levels of awareness regarding reproductive rights.

Growth is supported by increased adoption of Long-Acting Reversible Contraceptives (LARCs), including intrauterine devices (IUDs) and implants, valued for their efficacy and convenience. The surge in e-commerce and online pharmacies is making these products more accessible than ever, particularly in bustling cities. With more women joining the workforce and societal attitudes shifting, the demand for discreet and dependable birth control is on the rise. These powerful trends are transforming Asia-Pacific into a vibrant hub for innovation and market expansion.

global-market-geography
Get more information on this report

Contraceptive Devices Market Research Report Guidance:

  • The report includes qualitative and quantitative data in the Contraceptive Devices market across product type, type, distribution channel, and geography.
  • The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the Contraceptive Devices market.
  • Chapter 3 includes the research methodology of the study.
  • Chapter 4 further includes ecosystem analysis.
  • Chapter 5 highlights the major industry dynamics in the Contraceptive Devices market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
  • Chapter 6 discusses the Contraceptive Devices market scenario, in terms of historical market revenues, and forecast till the year 2033.
  • Chapters 7 to 10 cover Contraceptive Devices market segments by product type, type, distribution channel, and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America. They cover the market volume, revenue forecast, and factors driving the market.
  • Chapter 11 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
  • Chapter 12 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
  • Chapter 13 provides detailed profiles of the major companies operating in the Contraceptive Devices market. Companies have been profiled on the basis of their key facts, business descriptions, products and services, financial overview, SWOT analysis, and key developments.
  • Chapter 14, i.e., the appendix, is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

Contraceptive Devices Market News and Key Development:

The Contraceptive Devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the Contraceptive Devices market are:

  • In April 2024, Aspivix partnered with Bayer (Switzerland) AG to expand the adoption of its carevix® device, a suction-based cervical stabilizer that reduces pain and bleeding during IUD placement. The collaboration leverages Bayer’s marketing and educational outreach to gynecologists across Switzerland and aims to generate additional clinical evidence supporting the device’s patient-friendly design. The partnership addresses a major adoption barrier for IUDs, enhancing patient experience and supporting broader utilization in the contraceptive devices market.
  • In September 2024, CooperSurgical, a global leader in women’s healthcare, announced the launch of a new inserter designed for single-hand placement of Paragard®, which was recently approved by the U.S. Food and Drug Administration (FDA). The new single-hand inserter simplifies the placement process for healthcare providers, making Paragard an even more accessible contraceptive choice for both providers and patients.
  • In February 2025, Sebela Women’s Health announced FDA approval of MIUDELLA®, a next-generation, hormone-free copper intrauterine system (IUS) for pregnancy prevention for up to 3 years. MIUDELLA® features a small, flexible nitinol frame and a preloaded inserter for easier placement, using less than half the copper of existing copper IUDs. Clinical trials demonstrated 99% efficacy, low expulsion rates, and minimal discontinuations, making MIUDELLA® the first new hormone-free IUD approved in the U.S. in over 40 years. This launch expands contraceptive choices and addresses unmet demand for non-hormonal birth control options.

Key Sources Referred:

  • World Bank – Global Trade Indicators
  • World Trade Organization (WTO)
  • International Monetary Fund (IMF)
  • International Trade Administration (ITA)
  • Company Websites
  • Company Annual Reports
  • Company Investor Presentations

The List of Companies - Contraceptive Devices Market

  • Bayer AG
  • Pfizer Inc.
  • Janssen Global Services, LLC
  • Teva Pharmaceutical Industries Ltd.
  • Merck Sharp & Dohme Corp.
  • Mylan N.V.
  • Reckitt Benckiser Group plc.
  • Veru Inc.
  • Medisafe Distribution Inc.
  • CooperSurgical, Inc.
Frequently Asked Questions
How big is the Contraceptive Devices Market?

The Contraceptive Devices Market is valued at US$ 28.22 Billion in 2025, it is projected to reach US$ 45.65 Billion by 2033.

What is the CAGR for Contraceptive Devices Market by (2026 - 2033)?

As per our report Contraceptive Devices Market, the market size is valued at US$ 28.22 Billion in 2025, projecting it to reach US$ 45.65 Billion by 2033. This translates to a CAGR of approximately 6.05% during the forecast period.

What segments are covered in this report?

The Contraceptive Devices Market report typically cover these key segments-

  • Product Type (Hormonal Contraceptives, Barrier Contraceptives)
  • Type (Male Contraceptive Devices, Female Contraceptive Devices)
  • Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, and Others)

What is the historic period, base year, and forecast period taken for Contraceptive Devices Market?

The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Contraceptive Devices Market report:

  • Historic Period : 2022-2024
  • Base Year : 2025
  • Forecast Period : 2026-2033
  • Who are the major players in Contraceptive Devices Market?

    The Contraceptive Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Bayer AG
  • Pfizer Inc.
  • Janssen Global Services, LLC
  • Teva Pharmaceutical Industries Ltd.
  • Merck Sharp & Dohme Corp.
  • Mylan N.V.
  • Reckitt Benckiser Group plc.
  • Veru Inc.
  • Medisafe Distribution Inc.
  • CooperSurgical, Inc.
  • Who should buy this report?

    The Contraceptive Devices Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Contraceptive Devices Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now

    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)